Global Health IPO

Global Health IPO | Review

Spread the love

Global Health Limited has come up with an initial public offer (IPO). It will open on November 03-07, 2022 at Rs.319-336 a share. The IPO issue size is around Rs.2,205.57 crore. The minimum bid will be for 44 shares and in its multiples thereafter.


Global Health is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity and operating revenues. It operates in the North and East regions of India. It has key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.

Under the “Medanta” brand, the company has a network of five hospitals currently in operation (Gurugram, Indore, Ranchi, Lucknow and Patna) and one hospital (Noida), which is under construction. It provides healthcare services in over 30 medical specialties and engage over 1,300 doctors led by experienced department heads and, spanning an area of 4.7 million sq. ft. & operational hospitals have 2,467 installed beds.

In Fiscals 2020, 2021 and 2022 and the three months ended June 30, 2021 and 2022, company has generated income from healthcare services of Rs.14,805.71 million, Rs.14,178.41 million, Rs.21,003.95 million, Rs.4,732.10 million and Rs.5,960.89 381 million, respectively, and had EBITDA of Rs.2,304.54 million, Rs.2,228.52 million, Rs.4,897.57 million, Rs.1,057.69 million and Rs.1,416.46 million, respectively.



Dr. Naresh Trehan – 35%

Promoter Holding

Pre-Issue Shareholding – 35.00%Post-Issue Shareholding – 33.00%

Strength & Weakness

Focus on Clinical Research and AcademicsHighly dependent on doctors & nurses
Driven by skilled and experienced doctorsHealthcare services has high costs
Large-scale hospitals with sophisticated infrastructure, equipment and technologyDoesn’t have sufficient insurance coverage
Track record of operational and financial performanceSubject to medical and legal risks
Focus on under-served areas with dense populationRely on third-party suppliers and sub-contractors
Presence in top or capital cities of large statesDepend on financing from the banks or FIs to carry on business operations
Experienced senior management teamIncreased competition from other hospitals
Diversification into new servicesOutstanding litigation against Directors


Apollo HospitalsFortis Healthcare
Max HealthcareNarayana Hrudayalaya

Company Financials

YearRevenue (in Crore)Profit (in Crore)

Object of Issue

1) The Offer for Sale of Equity Shares by the Selling Shareholders 

2) For repayment/prepayment of borrowings, in full or part, of Subsidiaries – GHPPL and MHPL

3) General corporate purposes

Global Health IPO Lot Size

Retail (Min)144Rs.14,784
Retail (Max)13572Rs.1,92,192
S-HNI (Min)14616Rs.2,06,976
B-HNI (Max)682,992Rs.10,05,312

Global Health IPO Details

IPO Opening Date November 03, 2022
IPO Closing Date November 07, 2022
Face Value Rs.2 per Equity Share
IPO Price Rs.319-336 per share
Market Lot 44 shares
Minimum Order Quantity 44 shares
Listing At NSE, BSE
No. of shares offered (OFS)5,07,61,000 shares
Issue Size Up to Rs.2,205.57 Crore
QIB Shares Offered 50% of the offer
Retail Shares Offered 35% of the offer 
NII/HNI Shares Offered 15% of the offer 

Global Health IPO Timetable

IPO DateNovember 03-07, 2022
Allotment DateNovember 11, 2022
Initiation of RefundsNovember 14, 2022
Credit of share to Demat a/cNovember 15, 2022
IPO Listing DateNovember 16, 2022

Allotment Status

KFintech Technologies –

Book Lead Managers


About the author

Shankar Awale

Hey! I am Shankar Awale an aspiring blogger with an obsession for all things of Finance. This blog is dedicated to help people to learn about Financial Knowledge in easy language.

View all posts

Leave a Reply

Your email address will not be published. Required fields are marked *